Figure 3.
Scaled mean plasma naloxone concentrations after repeat administration at 3‐minute intervals (versus mean observed profiles of 0.4 mg intramuscular (i.m.) and 2 mg intranasal (i.n.) doses)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.